Nationwide Fund Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-12,732
| Closed | -$329K | – | 33 |
|
|
2017
Q3 | $329K | Buy |
12,732
+1,309
| +11% | +$33.8K | ﹤0.01% | 2392 |
|
|
2017
Q2 | $310K | Buy |
11,423
+4,796
| +72% | +$130K | ﹤0.01% | 2430 |
|
|
2017
Q1 | $198K | Buy |
6,627
+510
| +8% | +$15.2K | ﹤0.01% | 2596 |
|
|
2016
Q4 | $166K | Buy |
6,117
+370
| +6% | +$10K | ﹤0.01% | 2690 |
|
|
2016
Q3 | $147K | Hold |
5,747
| – | – | ﹤0.01% | 2769 |
|
|
2016
Q2 | $106K | Buy |
5,747
+1,838
| +47% | +$33.9K | ﹤0.01% | 2885 |
|
|
2016
Q1 | $74K | Buy |
3,909
+491
| +14% | +$9.3K | ﹤0.01% | 2902 |
|
|
2015
Q4 | $92K | Buy |
+3,418
| New | +$92K | ﹤0.01% | 2876 |
|